Melinta Therapeutics plan accepted by majority of voting creditors

By Caroline Salls

Pittsburgh, March 31 – Melinta Therapeutics, Inc.’s plan of reorganization was accepted by a majority of voting creditors, according to a ballot report filed Tuesday with the U.S. Bankruptcy Court for the District of Delaware.

All 12 holders of $854.56 million in secured pre-bankruptcy credit agreement claims voted to accept the plan.

In addition, 72 holders, or 94.74% in number, of $1,239,105,798, or 99.93% in amount, of general unsecured claims voted to accept the plan, while four holders, or 5.26% in number, of $868,599, or 0.07% in amount, of those claims voted to reject it.

The plan confirmation hearing is scheduled for April 2.

Melinta is an antibiotics company based in New Haven, Conn. The company filed bankruptcy on Dec. 27 under Chapter 11 case number 19-12748.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.